Close Menu
Home › NICE Draft Guidance Reverses Endorsement of Oncotype Dx to Guide Chemotherapy

NICE Draft Guidance Reverses Endorsement of Oncotype Dx to Guide Chemotherapy

Jan 10, 2018

NEW YORK (GenomeWeb) – A draft document published today by the UK's National Institute for Health and Care Excellence (NICE) reverses a previous endorsement for the use of Genomic Health's Oncotype Dx test in guiding chemotherapy decisions for breast cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Featured Webinar

A New Multiplex Syndromic System For Respiratory Diagnosis And Improved Patient Care

Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison (Part 2): Best NGS Approaches for Human Transcriptome Sequencing

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Featured Webinar

Advancing Agricultural Genomics with Low-Cost NGS Genotyping

Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

What's Popular?

In Molecular Diagnostics

  1. Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine

    Premium

  2. TGen Inks Tuberculosis Test Deal With Advanced Biological Laboratories

  3. SpeeDx Signs Distributor Deals in Middle East

  4. BRCA Screening Guidelines Too Reliant on Family History, Stakeholders Tell USPSTF

    Premium

  5. Biocept to Raise $8.2M in Direct Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.